Dextromethorphan attenuates ethanol withdrawal syndrome in rats

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 3, 1999, Pages 537-541

  Erden, B F ^a   Ozdemirci, S ^a   Yildiran, G ^a   Utkan, T ^a   Gacar, N ^a   Ulak, G ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Audiogenic seizure; Dextromethorphan; Ethanol withdrawal; N Methyl D aspartate

Indexed keywords

ALCOHOL; DEXTROMETHORPHAN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ALCOHOL ABSTINENCE; ALCOHOL BLOOD LEVEL; ANIMAL MODEL; ARTICLE; AUDIOGENIC SEIZURE; CONTROLLED STUDY; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WITHDRAWAL SYNDROME;

ACOUSTIC STIMULATION; ANIMALS; ANTITUSSIVE AGENTS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DEXTROMETHORPHAN; ETHANOL; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; SEIZURES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032977926     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00175-0     Document Type: Article

References (31)

1. Adams M.L., Sewing B.N., Chen J., Meyer E.R., Cicero T.J. Nitric oxide-related agents alter alcohol withdrawal in male rats. Alcohol. Clin. Exp. Res. 19:1995;195-199.
2. Albers G.W., Saenz R.E., Moses J.A., Choi D.W. Safety and tolerance of oral dextromethorphan in patients at risk for brain ischemia. Stroke. 22:1991;1075-1077.
3. Church J., Lodge D., Berry S. Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acids. Eur. J. Pharmacol. 111:1985;185-190.
4. Holtzman S.G. Discriminative stimulus effects of dextromethorphan in the rats. Psychopharmacology (Berlin). 116:1994;249-254.
5. Jaffe J. Drug addiction and drug abuse. Gilman A.G., Rall T.W., Wies A.S. Goodman and Gilman's The pharmacological basis of therapeutics. 1990;522-573 Pergamon Press, New York.
6. Kotlinska J., Liljequist S. Oral administration of glycine and polyamine receptor antagonists blocks ethanol-withdrawal seizures. Psychopharmacology (Berlin). 127:1996;238-244.
7. Koyuncuoglu H., Aricioglu F. Previous chronic blockade of NMDA receptors intensifies morphine dependence in rats. Pharmacol. Biochem. Behav. 39:1991;575-579.
8. Koyuncuoglu H. The combination of tizanidine markedly improves the treatment with dextromethorphan of heroin addicted outpatients. Int. J. Clin. Pharmacol. Ther. 33:1995;13-19.
9. Koyuncuoglu H. The treatment with L-aspartic acid of persons addicted to opiates. Bull. Narc. (United Nations Publication). 35:1983;11-15.
10. Koyuncuoglu H., Güngör M., Sagduyu H., Aricioglu F. Supression by ketamin and dextromethorphan of precipitated abstinence syndrome in rats. Pharmacol. Biochem. Behav. 35:1990;829-832.
11. Kumar N., Gow J.G. Residual solvent analysis by headspace gas chromatography. J. Chromatog. A. 667:1994;235-240.
12. Lovinger D., White G., Weight F. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science. 243:1989;1721-1723.
13. Majchrowicz E. Induction of physical dependence upon ethanol and the associated behavioral changes in rats. Psychopharmacologia. 43:1975;245-254.
14. Malec D., Kotlinska J., Langwinski R. Cross-tolerance between morphine and ethanol and their antinociceptive effects. J. Stud. Alcohol. 48:1987;507-510.
15. Mao J., Price D.D., Caruso F.S., Mayer D.J. Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats. Pain. 67:1996;361-368.
16. Marsh L.D., Key J.D., Spratt E. Bulimia and dextromethorphan abuse. J. Subst. Abuse Treat. 14:1997;373-376.
17. Morrisett R.A., Revzani A.H., Overstreet D., Janowsky D.S., Wilson W.A., Swartzwelder H.S. MK-801 potently inhibits alcohol withdrawal seizures in rats. Eur. J. Pharmacol. 176:1990;103-105.
18. Orrell M.W., Campbell P.G. Dependence on dextromethorphan hydrobromide. Br. Med. J. 293:1986;1242.
19. Prince D.A., Feeser H.R. Dextromethorphan protects against cerebral infarction in a rat model of hypoxia-ischemia. Neurosci. Lett. 85:1988;291-296.
20. Ripley T.L., Little H.J. Effects on ethanol withdrawal hyperexcitability of chronic treatment with a competitive N-methyl-D-aspartate receptor antagonist. J. Pharmacol. Exp. Ther. 272:1995;112-118.
21. Rossetti Z.L., Carboni S. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur. J. Pharmacol. 283:1995;177-183.
22. Sagratella S., Pezzola A., Popoli P., Carolis A.S. Different capability of N-methyl-D-aspartate antagonists to elicit EEG and behavioural phencyclidinelike effects in rats. Psychopharmacology (Berlin). 109:1992;277-282.
23. Sener A.I., Ceylan M.E., Koyuncuoglu H. Comparison of the supressive effects of L-aspartic acid and chlorpromazin + diazepam treatments on opiate abstinence syndrome signs in men. Drug Res. 36:1986;1684-1686.
24. Thompson W.L. Management of alcohol withdrawal syndromes. Arch. Intern. Med. 138:1978;278-283.
25. Tortella F.C., Pellicano M., Bowery N.G. Dextromethorphan and neuromodulation. Old drug coughs up new activities Trends Pharmacol. Sci. 10:1989;501-507.
26. Uzbay I.T., Erden B.F., Tapanyigit E.E., Kayaalp S.O. Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci. 61:1997;2197-2209.
27. Uzbay I.T., Erden B.F., Sever B. Effects of nitric oxide synthase inhibition on ethanol withdrawal syndrome in rats. Eur. Neuropsychopharmacol. 6:1996;130-131.
28. Uzbay I.T., Kayaalp S.O. A modified liquid diet of chronic ethanol administration. Validation by ethanol withdrawal syndrome in rats Pharmacol. Res. 31:1995;37-42.
29. Walker J., Yatham L.N. Benylin (dextromethorphan) abuse and mania. Br. Med. J. 306:1993;896.
30. Wolfe T.R., Caravati E.M. Massive dextromethorphan ingestion and abuse. Am. J. Emerg. Med. 13:1995;174-176.
31. Wu D., Otton S.V., Kalow W., Sellers E.M. Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rats. J. Pharmacol. Exp. Ther. 274:1995;1431-1437.